Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas Ciulla, MD
Clearside Biomedical
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retinal Consultants of Arizona and Retinal Research Institute
Phoenix, Arizona, United States
- Retina Centers, Pc
Tucson, Arizona, United States
- California Retina Consultants
Bakersfield, California, United States
- Retina Vitreous Medical Group Clinical Research
Beverly Hills, California, United States
- Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California, United States
- Retina Institute of California
Palm Desert, California, United States
- Retina Consultants San Diego
Poway, California, United States
- Medeye Associates
Miami, Florida, United States
- Retina Specialty Institute
Pensacola, Florida, United States
- Sarasota Retina Institute
Sarasota, Florida, United States
- Center for Retina and Macular Disease
Winter Haven, Florida, United States
- Emory Eye Center
Augusta, Georgia, United States
- Marietta Eye Clinic
Marietta, Georgia, United States
- Midwest Eye Institute
Indianapolis, Indiana, United States
- Retina and Vitrous Associates of Kentucky
Lexington, Kentucky, United States
- the Johns Hopkins Wilmer Eye Institute
Baltimore, Maryland, United States
- Cumberland Valley Retina Consultants
Hagerstown, Maryland, United States
- Retina Associates of Nj
Teaneck, New Jersey, United States
- Western Carolina Retinal Associates
Asheville, North Carolina, United States
- Oregon Retina Institute
Medford, Oregon, United States
- Black Hills Regional Eye Institute
Rapid City, South Dakota, United States
- Retina Research Institute of Texas
Abilene, Texas, United States
- Texas Retina Associates-Arlington
Arlington, Texas, United States
- Austin Retina Associates
Austin, Texas, United States
- Texas Retina Associates
Dallas, Texas, United States
- Valley Retina Institute
McAllen, Texas, United States
- Valley Retina Institute, P.A.
McAllen, Texas, United States
- Medical Center Ophthalmology Associates
San Antonio, Texas, United States
- Retina Consultants of Houston
The Woodlands, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jul 2017
- Primary completion
- 17 Apr 2018
- Completion
- 17 Apr 2018
- Last update posted
- 13 May 2021
- Registered enrollment
- 71
- Registry id
- NCT03126786
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.